GIP and type 2 diabetes mellitus: Immunoexpressionof the incretin hormones such as glucagon-like peptide-1 (GLP-1) and peptide YY(3-36) (PYY3-36) can be used as a scorer in the gastrointestinaltract to analyze L-cell activity in response to T2DM treatment.